basiliximab

Trials studying basiliximab

• phase4Simulect Versus ATG in Sensitized Renal Transplant Patientcompletedn=60
• phase2Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipientscompletedn=418
• phase2A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipientscompletedn=149
• phase4Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXRterminatedn=20
• phase2Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant Recipientscompletedn=67
• phase3Phase 3b Study to Evaluate Advagraf in Combination With Mycophenolate Mofetil and Basiliximab in Liver Transplantationcompletedn=893
• phase4A Study Looking at Diabetes in Kidney Transplant Recipients Receiving Immunosuppressive Regimen With or Without Steroidscompletedn=1,166
• phase3Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allograftscompletedn=281